Originally posted on 08/16/2014:

A) Their market cap is $63B, whatever "game changer" you're referencing most likely won't generate enough revenues to move the needle for this company.
B) if they're in phase one of trials, they're not FDA approved. Given that you don't know this, I can't take anything you say seriously
C) you reference some vague "game changer" and give no specifics. Really sound like you know what you're talking about there chief.

That's your first and last lesson, no more free lunches kiddo. If you want a real game changer check out SZYM. They make tailored oils to meet various market needs. It's revolutionary because they're making this all from algae and have finally gotten their plants up and running (and operating smoothly), thus revenues and profits are about to explode. This stock could be over $100 within 5 years if they execute. There's always risks but the rewards for Solazyme outweigh the risk, and it's not some measley 50% gain like you're referencing with that MGT garbage. Cheers.

Disclosure: long SZYM with no intentions to sell within the next 5-10 years.